Live Breaking News & Updates on Bulgarian Pharmaceutical
Stay updated with breaking news from Bulgarian pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bulgaria struggles with severe shortage of diabetes drugs euractiv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from euractiv.com Daily Mail and Mail on Sunday newspapers.
BG Ministry of Health: Info Campaign on Vaccines with Active Participation of GPs is in the Works - Novinite.com novinite.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from novinite.com Daily Mail and Mail on Sunday newspapers.
Send to Kindle Bulgarians live seven years less than citizens of the most developed countries in the European Union. In addition, we pay the highest surcharge for medicines - 37 per cent versus 5 per cent compared to other European Union countries, shows the report of Together for More Health initiative which includes representatives of the Bulgarian Medical Union (BMA) and the Bulgarian Pharmaceutical Union. Data for 2017 show that only 4.2% of Bulgaria’s GDP is allocated for healthcare annually, compared with an average of 8% for the rest of the EU. At the current rate of investment in healthcare, it will take 50 years to ....
There is a problem with medicines like Clexan and Fraxiparin for example. There are objective reasons for their absence, but this must be discussed. Neglecting the problem will not solve it. This was stated in an interview by Prof. Asena Serbezova - Chairwoman of the Bulgarian Pharmaceutical Union. Indeed, there is an increased consumption of these products because they enter the therapeutic treatment. There are objective reasons for their absence. Every country has a plan about medicine supplies. But pharmaceutical companies can be called for discussion. The Medicines Agency could have been tougher in the negotiations. There was a way to predict that these drugs would start to run out as soon as the first treatment protocols began to appear on social networks. ....